These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 10403523

  • 1. Cell cycle-dependent distribution and specific inhibitory effect of vectorized antisense oligonucleotides in cell culture.
    Hélin V, Gottikh M, Mishal Z, Subra F, Malvy C, Lavignon M.
    Biochem Pharmacol; 1999 Jul 01; 58(1):95-107. PubMed ID: 10403523
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C, D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro G C, Zupi G.
    J Natl Cancer Inst; 1996 Apr 03; 88(7):419-29. PubMed ID: 8618233
    [Abstract] [Full Text] [Related]

  • 4. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
    Normand N, Valamanesh F, Savoldelli M, Mascarelli F, BenEzra D, Courtois Y, Behar-Cohen F.
    Mol Vis; 2005 Mar 04; 11():184-91. PubMed ID: 15761390
    [Abstract] [Full Text] [Related]

  • 5. Sequence-specific inhibition of gene expression in intact human skin by epicutaneous application of chimeric antisense oligodeoxynucleotides.
    Wingens M, Pfundt R, van Vlijmen-Willems IM, van Hooijdonk CA, van Erp PE, Schalkwijk J.
    Lab Invest; 1999 Nov 04; 79(11):1415-24. PubMed ID: 10576212
    [Abstract] [Full Text] [Related]

  • 6. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth.
    Williams SA, Chang L, Buzby JS, Suen Y, Cairo MS.
    Leukemia; 1996 Dec 04; 10(12):1980-9. PubMed ID: 8946941
    [Abstract] [Full Text] [Related]

  • 7. Uptake and efflux of intact antisense phosphorothioate deoxyoligonucleotide directed against angiotensin receptors in bovine adrenal cells.
    Li B, Hughes JA, Phillips MI.
    Neurochem Int; 1997 Sep 04; 31(3):393-403. PubMed ID: 9246681
    [Abstract] [Full Text] [Related]

  • 8. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M, Shchepinov M, Sohail M, Benter IF, Hollins AJ, Southern EM, Akhtar S.
    J Control Release; 2004 Sep 14; 99(1):139-55. PubMed ID: 15342187
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antisense downregulation of SARS-CoV gene expression in Vero E6 cells.
    Shi Y, Luo H, Jia J, Xiong J, Yang D, Huang B, Jin Y.
    J Gene Med; 2005 Jan 14; 7(1):97-107. PubMed ID: 15543523
    [Abstract] [Full Text] [Related]

  • 11. Improving the intracellular delivery and molecular efficacy of antisense oligonucleotides in chronic myeloid leukemia cells: a comparison of streptolysin-O permeabilization, electroporation, and lipophilic conjugation.
    Spiller DG, Giles RV, Grzybowski J, Tidd DM, Clark RE.
    Blood; 1998 Jun 15; 91(12):4738-46. PubMed ID: 9616172
    [Abstract] [Full Text] [Related]

  • 12. 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
    Yoo BH, Bochkareva E, Bochkarev A, Mou TC, Gray DM.
    Nucleic Acids Res; 2004 Jun 15; 32(6):2008-16. PubMed ID: 15064360
    [Abstract] [Full Text] [Related]

  • 13. Specific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by liposomally encapsulated antisense phosphorothioate oligonucleotides in MDCK cells.
    Abe T, Suzuki S, Hatta T, Takai K, Yokota T, Takaku H.
    Antivir Chem Chemother; 1998 May 15; 9(3):253-62. PubMed ID: 9875404
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of hepadnaviral replication by polyethylenimine-based intravenous delivery of antisense phosphodiester oligodeoxynucleotides to the liver.
    Robaczewska M, Guerret S, Remy JS, Chemin I, Offensperger WB, Chevallier M, Behr JP, Podhajska AJ, Blum HE, Trepo C, Cova L.
    Gene Ther; 2001 Jun 15; 8(11):874-81. PubMed ID: 11423935
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides.
    Dheur S, Dias N, van Aerschot A, Herdewijn P, Bettinger T, Rémy JS, Hélène C, Saison-Behmoaras ET.
    Antisense Nucleic Acid Drug Dev; 1999 Dec 15; 9(6):515-25. PubMed ID: 10645777
    [Abstract] [Full Text] [Related]

  • 18. Control of intracellular delivery of oligonucleotides by signal peptides and genetic expression in human cells.
    Kubo T, Kanno K, Ohba H, Rumiana B, Fujii M.
    Nucleic Acids Symp Ser (Oxf); 2004 Dec 15; (48):303-4. PubMed ID: 17150599
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C, Wellham LL.
    Anticancer Res; 2003 Dec 15; 23(3B):2681-90. PubMed ID: 12894558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.